Ureteral carcinoma
Classification according to ICD-10 | |
---|---|
C66 | Malignant neoplasm of the ureter |
ICD-10 online (WHO version 2019) |
A Ureterkarzinom or ureter is a rare malignant tumor of the ureter , which in over 95% of cases as urothelial carcinoma and 2-3%, especially in kidney stone patients as squamous occurs. The peak of the disease is 50 to 60 years of age. The ratio of men to women is 2 to 3: 1.
Symptoms
- Traces of blood in the urine as microhematuria , d. H. only recognizable by tests or as macrohematuria , d. H. Blood discharges are visible
- unilateral urine congestion can also occur
diagnosis
Means ureterorenoscopy an endoscopic inspection of the ureter and possibly a is biopsy performed.
therapy
- Radical ureteronephrectomy with a bladder cuff is recommended for cancer of the upper urinary tract .
- Endoscopic, organ-preserving procedures ( resection or laser treatment) can be used for well-differentiated smaller carcinomas.
literature
- Elmar Stöcker and C. Enghausen: On the increase in primary ureteral carcinoma . Z. Urol. 50: 406-416 (1957).
- Daniel J. Painter et al: The modern management of upper urinary tract urothelial cancer. Tumor diagnosis, grading and staging. In: BJU International . 99 (2007), pp. 973-977.
Web links
Individual evidence
- ↑ Janet Lehmann et al .: Transitional Cell Carcinoma of the Ureter: Prognostic Factors Influencing Progression and Survival In: European Urology . 2007; 51, pp. 1281-1288, PMID 17125909
- ↑ Willem Oosterlinck: Ureteral Tumor: A Specific Upper Urinary Tract Transitional Cell Carcinoma In: European Urology. 2007; 51, pp. 1164-1165, PMID 17161524 .